4.4 Article

P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics

Bo Chen et al.

Summary: Neuroblastoma is the most common extracranial solid tumor in children, and finding new valid therapeutic targets for NB is crucial. This study identified differentially expressed genes associated with NB through comprehensive bioinformatic analysis, providing potential diagnostic indicators and therapeutic biomarkers for improving NB treatment.

INVESTIGATIONAL NEW DRUGS (2021)

Article Biochemistry & Molecular Biology

Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling

Zhenlin Wang et al.

Summary: PLOD1 is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer, particularly associated with the progression of the most malignant mesenchymal subtype in GBM. Molecular experiments and tumor xenograft models demonstrated that PLOD1 overexpression promotes tumor viability, proliferation, migration, and mesenchymal transition, with an association to the NF-kappa B signaling pathway. High PLOD1 expression may be a potential treatment target for mesenchymal GBM or even all GBM by enhancing tumor invasiveness.

ONCOGENE (2021)

Article Multidisciplinary Sciences

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases

Lei Tian et al.

Summary: In gliomas, high expression of PLOD1 is associated with poor survival and can serve as an oncogenic factor and independent prognostic indicator. The high expression of PLOD1 is enriched in ECM-related pathways, and its positive correlation with various genes also linked to poor prognosis of glioma. Targeting PLOD1 may be a potential therapeutic strategy for glioma patients.
Article Mathematical & Computational Biology

P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma

Xiangfeng Jin et al.

Summary: This study evaluated the functional and clinical values of P3H4 in lung adenocarcinoma (LUAD) and found that P3H4 may promote LUAD progression through regulating tumor microenvironment-related pathways.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)

Article Oncology

Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile

Jean Hoffman-Censits et al.

Summary: This study identified small cell/neuroendocrine features in some bladder cancer and upper tract urothelial cancer samples, with mutations in genes like TP53 and RB1, as well as differential gene expression compared to urothelial bladder cancer. These findings may explain the aggressive phenotype of small cell bladder cancer.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma

Xiaolin Wu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Oncology

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

Atif Ali Hashmi et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)

Article Oncology

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts

Torben Frostrup Hansen et al.

BRITISH JOURNAL OF CANCER (2018)

Review Genetics & Heredity

Role of Non-Coding RNAs in the Etiology of Bladder Cancer

Caterina Gulia et al.

Article Clinical Neurology

A Case of Ehlers-Danlos Syndrome Type VIA With a Novel PLOD1 Gene Mutation

Ayse Tosun et al.

PEDIATRIC NEUROLOGY (2014)

Review Biochemistry & Molecular Biology

Lysine post-translational modifications of collagen

Mitsuo Yamauchi et al.

LYSINE-BASED POST-TRANSLATIONAL MODIFICATION OF PROTEINS (2012)

Article Multidisciplinary Sciences

Complex humoral immune response against a benign tumor: Frequent antibody response against specific antigens as diagnostic targets

N Comtesse et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)